Expression of the Wilms' tumour gene and its association with PPARβ/δ in healthy skin and melanoma of horses
- PMID: 33459615
- DOI: 10.1556/004.2020.00045
Expression of the Wilms' tumour gene and its association with PPARβ/δ in healthy skin and melanoma of horses
Abstract
The Wilms' tumour gene (WT1) has previously been described as an oncogene in several neoplasms of humans, including melanoma, and its expression increases cancer cell proliferation. Recent reports associate the expression of the PPARβ/δ gene (peroxisome proliferator-activated receptor beta/delta) with the downregulation of WT1 in human melanoma and murine melanoma cell lines. The aim of this work was to analyse the expression of WT1 and its association with PPARβ/δ in samples of healthy and melanoma-affected skin of horses by immunohistochemistry. WT1 protein expression was detected in healthy skin, mainly in the epidermis, hair follicle, sebaceous gland and sweat gland, while no expression was observed in equine melanoma tissues. Moreover, it was observed that PPARβ/δ has a basal expression in healthy skin and that it is overexpressed in melanoma. These results were confirmed by a densitometric analysis, where a significant increase of the WT1-positive area was observed in healthy skin (128.66 ± 19.84 pixels 106) compared with that observed in melanoma (1.94 ± 0.04 pixels 106). On the other hand, a positive area with an expression of PPARβ/δ in healthy skin (214.94 ± 11.85 pixels 106) was significantly decreased compared to melanoma (624.86 ± 181.93 pixels 106). These data suggest that there could be a regulation between WT1 and PPARβ/δ in this disease in horses.
Keywords: PPARβ/δ gene; WT1 gene; equine; melanoma; skin.
Similar articles
-
PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.Pflugers Arch. 2010 Apr;459(5):689-703. doi: 10.1007/s00424-009-0776-6. Epub 2010 Jan 12. Pflugers Arch. 2010. PMID: 20066433 Free PMC article.
-
The Role of PPARβ/δ in Melanoma Metastasis.Int J Mol Sci. 2018 Sep 20;19(10):2860. doi: 10.3390/ijms19102860. Int J Mol Sci. 2018. PMID: 30241392 Free PMC article.
-
Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer.EMBO Mol Med. 2014 Jan;6(1):80-98. doi: 10.1002/emmm.201302666. EMBO Mol Med. 2014. PMID: 24203162 Free PMC article.
-
Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.Mol Carcinog. 2019 Sep;58(9):1612-1622. doi: 10.1002/mc.23033. Epub 2019 May 6. Mol Carcinog. 2019. PMID: 31062422 Free PMC article. Review.
-
Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease.Biomol Concepts. 2013 Feb;4(1):53-64. doi: 10.1515/bmc-2012-0035. Biomol Concepts. 2013. PMID: 25436565 Review.
Cited by
-
The Expression of PPAR Pathway-Related Genes Can Better Predict the Prognosis of Patients with Colon Adenocarcinoma.PPAR Res. 2022 Apr 18;2022:1285083. doi: 10.1155/2022/1285083. eCollection 2022. PPAR Res. 2022. PMID: 35481240 Free PMC article.
-
Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.Cells. 2022 Aug 5;11(15):2432. doi: 10.3390/cells11152432. Cells. 2022. PMID: 35954274 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical